Literature DB >> 19765763

Bladder function after total urogenital mobilization for persistent cloaca.

Futoshi Matsui1, Kenji Shimada, Fumi Matsumoto, Takashi Obara, Akio Kubota.   

Abstract

PURPOSE: Total urogenital mobilization has achieved widespread use because it avoids surgical complications of vaginal reconstruction. We used urodynamic studies to assess bladder function and urological outcomes after definitive repair by total urogenital mobilization.
MATERIALS AND METHODS: We identified 27 girls diagnosed with persistent cloaca between 1991 and 2008. We retrospectively reviewed the records of 11 patients (median age 14 months) who underwent reconstruction of the cloaca by total urogenital mobilization. Urinary continence was assessed in 7 patients older than 4 years. Urodynamic studies were performed postoperatively in 7 patients. Median followup was 72 months.
RESULTS: Rate of surgical complications was 9%. Urinary continence was achieved in 6 patients (86%), while 1 patient (14%) remained incontinent. Of the continent patients 3 (43%) voided spontaneously and 3 (43%) required clean intermittent catheterization. Urodynamic studies showed detrusor underactivity or acontractile detrusor in all patients during the voiding phase. Bladder compliance was normal in 6 patients (86%) and poor in 1 (14%). Detrusor overactivity was seen in 5 patients (71%) but resolved on followup in 2 (40%). Rate of continence was higher in the absence of detrusor overactivity (1 of 1 patient vs 2 of 3 with detrusor overactivity).
CONCLUSIONS: Most patients with persistent cloaca can achieve urinary continence after total urogenital mobilization. Two-thirds of patients display bladder dysfunction after the procedure. Detrusor overactivity can resolve with development of the bladder but persistent detrusor overactivity might delay the achievement of mechanisms of urinary continence.

Entities:  

Mesh:

Year:  2009        PMID: 19765763     DOI: 10.1016/j.juro.2009.07.052

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Therapeutic strategy for persistent cloaca: the efficacy of antegrade continent enema as a salvage surgery.

Authors:  Akio Kubota; Keigo Nara; Hisayoshi Kawahara; Akihiro Yoneda; Hiroshi Nakai; Taro Goda; Soji Ibuka; Futoshi Matsui; Kenji Shimada
Journal:  Pediatr Surg Int       Date:  2011-05       Impact factor: 1.827

Review 2.  Treatment guidelines for persistent cloaca, cloacal exstrophy, and Mayer-Rokitansky-Küster-Häuser syndrome for the appropriate transitional care of patients.

Authors:  Masayuki Kubota; Yutaka Osuga; Kiyoko Kato; Kenji Ishikura; Kazunari Kaneko; Kohhei Akazawa; Takeo Yonekura; Yuko Tazuke; Satoshi Ieiri; Akihiko Fujino; Shigeru Ueno; Yutaro Hayashi; Kaoru Yoshino; Toshihiro Yanai; Jun Iwai; Takanori Yamaguchi; Shintaro Amae; Yuichiro Yamazaki; Yoshifumi Sugita; Miyuki Kohno; Yutaka Kanamori; Yuko Bitoh; Masato Shinkai; Yasuharu Ohno; Yoshiaki Kinoshita
Journal:  Surg Today       Date:  2019-04-22       Impact factor: 2.549

Review 3.  Postoperative complications after reconstructive surgery for cloacal malformations: a systematic review.

Authors:  H P Versteegh; J R Sutcliffe; C E J Sloots; R M H Wijnen; I de Blaauw
Journal:  Tech Coloproctol       Date:  2015-02-22       Impact factor: 3.781

4.  Efficacy of solifenacin in the prevention of short-term complications after laparoscopic radical prostatectomy.

Authors:  Ranxing Yang; Lijie Liu; Gaofeng Li; Jianjun Yu
Journal:  J Int Med Res       Date:  2017-06-29       Impact factor: 1.671

5.  Urogenital Management in Cloaca: An Alternative Approach.

Authors:  Harshjeet Singh Bal; Sudipta Sen; Cenita Sam; Jacob Chacko; John Mathai; S R Regunandan
Journal:  J Indian Assoc Pediatr Surg       Date:  2017 Apr-Jun

6.  Persistent Cloaca: A Long-term Follow-up Study.

Authors:  Dinesh H Kittur; Ravindra M Vora
Journal:  J Indian Assoc Pediatr Surg       Date:  2017 Apr-Jun

Review 7.  The long-term management and outcomes of cloacal anomalies.

Authors:  M Ashani Fernando; Sarah M Creighton; Dan Wood
Journal:  Pediatr Nephrol       Date:  2014-09-13       Impact factor: 3.714

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.